Reuters logo
9 months ago
BRIEF-3D signatures plans to announce clinical trial for Hodgkin's Lymphoma precision medicine test in coming months
October 17, 2016 / 2:12 PM / 9 months ago

BRIEF-3D signatures plans to announce clinical trial for Hodgkin's Lymphoma precision medicine test in coming months

1 Min Read

Oct 17 (Reuters) - 3d Signatures Inc :

* 3DS plans to announce a clinical trial for a Hodgkin's Lymphoma precision medicine test in coming months

* Expects to engage laboratory partner in validation, approval of a Hodgkin's Lymphoma Laboratory Developed Test (LDT) for Canada in 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below